The study also confirmed previous findings that GLP-1 receptor agonists protect cardiovascular health, with a 14% reduction in the risk of cardiovascular death, non-fatal heart attack, and non-fatal stroke, compared to placebo
In September 2014, the medication CONTRAVE (naltrexone HCI and bupropion HCI) was approved for use in patients with a body mass index (BMI) of 30 (obesity) or more without weight-related medical conditions or a BMI of 27 or greater with a weight-related medical condition
Four interlocking changes define the midlife metabolic environment
The reactions were quenched by boiling with Laemmli sample buffer for 5 min
As bananas ripen and develop brown spots, starches convert to simple sugars, potentially causing faster blood glucose elevation
Our study also suggests that the glucose-lowering property of TH could be further exploited for the development of therapeutic strategies to treat type 2 diabetes